Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -0.11% | 484.30 | 1.0% | $762.51m | |
| DHR | Danaher Corp. | 0.22% | 243.38 | 0.7% | $658.96m | |
| ABT | Abbott Laboratories | -0.02% | 122.96 | 0.8% | $608.35m | |
| MDT | Medtronic Plc | 0.15% | 123.78 | 0.6% | $602.43m | |
| ALGN | Align Technology, Inc. | 0.00% | 595.63 | 6.3% | $368.57m | |
| ISRG | Intuitive Surgical, Inc. | 0.00% | 794.50 | 2.3% | $352.33m | |
| SYK | Stryker Corp. | 0.03% | 253.64 | 1.3% | $305.35m | |
| DXCM | DexCom, Inc. | 0.00% | 388.10 | 7.8% | $281.39m | |
| BDX | Becton, Dickinson & Co. | -0.08% | 250.50 | 1.0% | $275.46m | |
| NVCR | NovoCure Ltd. | -3.26% | 190.90 | 6.8% | $264.21m | |
| BSX | Boston Scientific Corp. | -0.08% | 39.38 | 1.0% | $248.68m | |
| EW | Edwards Lifesciences Corp. | 0.00% | 86.44 | 0.4% | $228.81m | |
| IDXX | IDEXX Laboratories, Inc. | 0.00% | 516.94 | 3.7% | $226.34m | |
| BAX | Baxter International, Inc. | 0.00% | 84.79 | 1.8% | $220.81m | |
| A | Agilent Technologies, Inc. | 0.05% | 133.04 | 1.6% | $187.80m |
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.